Opinion|Videos|March 7, 2025
Supporting Patients Through Treatment for Upper GI Cancer Care
Experts discuss the role of supportive therapies, such as antiemetics, nutritional support, and physical activity, in improving outcomes and patient comfort during treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following:
What role do supportive therapies, such as antiemetics, nutritional support, and physical activity, play in improving outcomes and patient comfort during treatment?
Advertisement
Related to this article
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma
2
FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC
3
Why Using AI to Interpret Mammogram Results Can Cause Unnecessary Panic
4
Prostate Cancer Care: ADT Management and APP Guidance
5